Viewing stories from August, 2013
Starpharma annual report and full year financial results
Starpharma today released its annual report and financial results for the year ended 30 June 2013.
Financial Results
- Net cash burn for the year $9.0M
- Cash position at end of the year $33.8M
- Reported loss $5.2M
Starpharma presentation at Canaccord Genuity Annual Growth Conference
Starpharma has announced that Chief Executive Officer Dr Jackie Fairley will present at the Canaccord Genuity 33rd Annual Growth Conference in Boston on August 14. The event brings together around 200 companies from diversified industry sectors, and selected from around the world based on their high growth potential.